17-63918770-T-G
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_000515.5(GH1):c.7A>C(p.Thr3Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000281 in 1,613,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T3A) has been classified as Likely benign.
Frequency
Consequence
NM_000515.5 missense
Scores
Clinical Significance
Conservation
Publications
- isolated growth hormone deficiency type IAInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- isolated growth hormone deficiency type IIInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- isolated growth hormone deficiency type IBInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- short stature due to growth hormone qualitative anomalyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GH1 | NM_000515.5 | c.7A>C | p.Thr3Pro | missense_variant | Exon 1 of 5 | ENST00000323322.10 | NP_000506.2 | |
| GH1 | NM_022559.4 | c.7A>C | p.Thr3Pro | missense_variant | Exon 1 of 5 | NP_072053.1 | ||
| GH1 | NM_022560.4 | c.7A>C | p.Thr3Pro | missense_variant | Exon 1 of 4 | NP_072054.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000394 AC: 60AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000232 AC: 58AN: 249884 AF XY: 0.000222 show subpopulations
GnomAD4 exome AF: 0.000269 AC: 393AN: 1460778Hom.: 0 Cov.: 35 AF XY: 0.000263 AC XY: 191AN XY: 726758 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000394 AC: 60AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74478 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
In silico analysis suggests that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
not specified Benign:1
Variant summary: GH1 c.7A>C (p.Thr3Pro) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00023 in 249884 control chromosomes in the gnomAD database, including 1 homozygote. The observed variant frequency is approximately 4 fold of the estimated maximal expected allele frequency for a pathogenic variant in GH1 causing Idiopathic Growth Hormone Deficiency phenotype (6.3e-05), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.7A>C in individuals affected with Idiopathic Growth Hormone Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. The following publications have been ascertained in the context of this evaluation (PMID: 17223997, 18950677). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at